Abstract: Antimicrobial resistance is still a crucial global problem related to the overuse of antibiotics and natural microorganism capability for rapid horizontal evolution. Even new generations of drugs are not able to overcome bacterial defence mechanisms. A novel solution for this immense medical challenge can be nanomaterials. Researchers indicate that modern nanoforms can effectively support and perhaps in the long-term replace traditional bactericidal agents. Because of their unique physicochemical properties, nanotechnology products can exert multiple actions against bacteria, which might be efficient against even multidrug-resistant pathogens. In this review, we discuss the documented achievements and concerns associated with broad potential applications of nanoforms in the fight against microorganisms.
Introduction
Nanotechnology has recently become one of the most fascinating and inspiring branches of science, which broadly enters biology and medicine [1] . Different forms of nanomaterials, especially nanoparticles and nanolayers, are investigated as antimicrobial factors. The small size (1-100 nm) of nanomaterials gives them unique chemical, physical and electronic properties, which are different from original bulk materials. There are two key characteristics: surface effects (causing smooth properties scaling due to atoms at the surface) and quantum effects (causing discontinuous behaviour in materials with delocalised electrons); these are responsible for the chemical reactivity and physical properties of nanomaterials [2] . In comparison to bulk materials, nanostructures play a role of reactants rather than catalysing agents [3] . Some features of nanoparticles, such as size, shape, surface functionalisation and obviously kind of chemical element, may significantly determine the interaction between nanomaterials and bacteria. Investigations in recent years have demonstrated that the electromagnetic, optical and catalytic properties of noblemetal nanoparticles are significantly influenced by the size and shape [4] . Regarding size, nanostructures are similar to many molecules playing a functional and informative role for cells of bacteria like membrane and cell wall receptors, active centres of enzymes, antigens or nucleic acids. These biomimetic traits of nanostructure, together with their high surface:volume ratio affect the interaction and reactivity of nanostructures with bacteria. Some experiments revealed that noble-metal nanoparticles undergo size-dependent interactions with bacteria and viruses [5] [6] [7] .
It has also been shown that smaller nanoparticles can penetrate cellular and nuclear membranes more easily and interact with intracellular structures [8, 9] . Moreover, some authors suggested that nanoparticles < 10 nm show properties similar to gas, which can easily enter living cells [10] .
Also, the shape of nanoparticles can influence their antimicrobial activities. In experiments with gram-negative bacteria (G-) it was discovered that silver nanoparticles undergo shape-dependent interactions with Escherichia coli [11] . However, little is known about the influence of the shape of nanostructures on their bio-activities. The key properties of nanostructures depend on chemical groups, which are present at their surface. The type of these groups is mainly the result of the production method and the subsequent functionalisation of nanoparticles. The groups which are bound to nanostructures are available for chemical reaction and functionalisation with compounds in their environment and can affect hydrophobic or hydrophilic activities as well as biocompatibilities. Generally, oxide nanoparticles are often used to immobilise biomolecules due to their biocompatibility [3] . Furthermore, the surface coatings can reduce the toxicity of harmful particles, while, on the other hand, less harmful particles can become highly toxic. The transition metals, ozone and oxygen present on the nanoparticle surface can create reactive oxygen species (ROS) and induce inflammation [2] . The activity of nanostructures is determined by the elements and their allotropic forms. In the case of nanoparticles originating from metal elements, there are indications that aggregates of silver nanoparticles are more toxic than asbestos, while titanium oxide, alumina, iron oxide and zirconium oxide nanoparticles were found to be less toxic [12] . Carbon structures are relatively friendly and biocompatible, yet some studies have shown diversity in the toxic effects, demonstrating the toxic effects of nanotubes and less toxic effect of graphene, alongside the lack of toxicity of diamond nanoparticles [13] [14] [15] . The toxicity of nanomaterials against bacteria is relatively a new research concept, but there are now several important results. Therefore, in this review, we present documented achievements and concerns associated with broad potential applications of nanomaterials in a fight with microorganisms.
Bacterial resistance and mechanism of actions
The antimicrobial resistance problem is related to the overuse of antibiotics in human and veterinary medicine [16] . This issue is not new, but still relevant according to the WHO report on antimicrobial resistance [17] . Both traditional and modern antibacterial therapies generally fall within one of the five mechanisms of action [18] . The most common utilises the inhibition of bacterial cell wall synthesis. In this mechanism, for instance, β-lactams exert bactericidal activity through covalently binding to essential enzymes, known as penicillin-binding proteins, resulting in interference with the synthesis and remodelling of the bacterial cell wall [19] . Another strategy is the inhibition of bacterial protein synthesis. Aminoglycosides and tetracyclines selectively inhibit bacterial growth by binding to the ribosome 30S subunit, whereas chloramphenicol binds to the 50S subunit [20] . The third way is the disruption of nucleic acid synthesis, which is a characteristic action of nitrofurans. In the fourth mechanism, antibiotics, such as sulphonamides, block metabolic pathways, including folic acid synthesis. Finally, the activity of polymyxins results in the disruption and permeability of the bacterial membrane structure [21] . The sensitivity of pathogens to bacteriostatic and bactericidal substances depends on their structure. Bacteria have a specific membrane and cell wall construction, which forms the osmotic barrier and protects them from mechanical factors. Bacterial cell walls exhibit significant differences in the structure, composition and function. The cell wall of gram-positive (G+) bacteria is composed of many peptidoglycan layers, with a thickness of 20-80 nm, additionally functionalised by teichoic acid polymers, which are responsible for resistance to β-lactams and penicillin [22] . In contrast, G-bacteria have a much thinner peptidoglycan layer (2-10 nm), but it is strengthened by the outer membrane. This membrane is composed of phospholipids and contains unique lipopolysaccharides (LPS) on its outer leaflet, which ensure the antigenic specificity [23] . This kind of membrane structure may ensure resistance to hydrophobic drugs. Therefore, G-bacteria are less sensitive to β-lactams and macrolides [24] , which is an example of natural resistance. Another type of microorganism resistance is acquired resistance. The bacteria that are initially susceptible to an antimicrobial agent can become resistant to the agent. This can result from the mutation of genes involved in normal physiological processes, horizontal gene transfer or both processes. Horizontal gene transfer takes place through the acquisition of foreign genetic material from other resistant organisms, and may occur via three main mechanisms: conjugation, transduction or transformation ( Figure 1A) . A special kind of bacteria resistance is multidrug resistance, defined as resistance to at least three antibacterial drug classes; this occurs most commonly in hospitals and healthcare institutions [20] . A popular G-bacteria mechanism of resistance is the decreased uptake and increased efflux of antibacterial agents ( Figure 1B ). The aim of this action is to prevent toxic concentrations of a drug within the cell [25] . This phenomenon is often observed in Gspecies, such as E. coli and Pseudomonas aeruginosa, which actively remove many types of antibiotics through ion-proton gradient transmembrane pumps. The multidrug efflux pumps can remove harmful substances directly outside the bacterial cell as a result of mutations that cause overexpression of regulatory efflux proteins [26] . Genes that encode proteins of the efflux pump are located on chromosomes or mobile genetic elements, such as transposons or plasmids. Highly conserved chromosomal genes that promote drug resistance are activated by the induction of a substrate or through mutations in the regulatory genes, induced by environmental stress [27] . In turn, substrate-specific efflux mechanisms are encoded on plasmids, transposons or integrons [28] . Resistance to ammonium salts, a common component of the surface disinfecting products, can develop in this way [24] . Another resistance mechanism is based on the modification of critical target sites to evade antimicrobials ( Figure 1B) . The action requires activation of the expression of specific genes, which are responsible for encoding alternative versions of drug target production. Changed substrates have a lower affinity to antimicrobial agents, and thereby the effectiveness of therapies is decreased [25] . This action is characteristic for G+ bacteria, with resistance to chinolon antibiotics, exhibiting transformed topoisomerase IV and gyrase [29] . Microorganisms can also influence the activity of drugs such as β-lactams, by the covalent modification and hydrolysis of the β-lactam ring ( Figure 1B ) [30] . Furthermore, they can synthesise inhibitory elements against antibiotic substances. This approach is observed in Streptococcus pneumoniae (G+), which showed an increased level of p-aminobenzoic acid, a hypercompetitive compound to antibiotics [31] .
Another problem in the fight against bacterial drug resistance is the cessation of antibiotic therapy too early, so that the disease recurs and the bacteria which survived can develop resistance. Therefore, treating them for the second time is more difficult, due to multidrug tolerance caused by a small subpopulation of microbial cells termed persisters [32] . Persisters are dormant cells from the million bacteria population, which slow down or stop metabolism, and can survive antimicrobial treatments [25] . This type of cell is commonly present in microbial biofilms in a specific, bacteria-friendly environment that is stable for microorganisms ( Figure 1C) . The biofilm is a structured microbial community, which is characterised by adhesion to a surface and the production of a matrix [33] . Biofilms can develop on solid abiotic surfaces by adhesion to the living organism tissue or on medical implants, which are naturally coated with the nutritional host protein layer, featuring electrostatic forces or London dispersion forces. The formation of biofilms is regulated by environmental and physiological factors, such as bacterial cell density, cellular stress and nutrient availability [33] . This highly organised community develops by multiplying and capturing free, planktonic cells, and can be composed of various species of bacteria, enclosed within an extracellular matrix [34] . The core of cell-to-cell interconnecting matrices constitutes polysaccharides, proteins and nucleic acids [35] . The matrix also contains a variety of cell appendages such as fimbriae, pili and flagella [36] . The community is able to transport nutrient from the outside of a biofilm, and also dispose of the metabolism waste [25] . In such environments, cells are well protected from adverse factors, such as the immune response of a host or to antibiotics [36] . The mature biofilm develops a characteristic ability of quorum-sensing, which is the method of microorganism communication [37] . As Shen et al. [38] observed, mature biofilms are more resistant to pharmacologic therapies than young ones, as a result of better opportunities to acquire new genes that are responsible for encoding new enzymes or metabolic pathways [39] . Another benefit of the biofilm formation is a negative charge of the matrix, which is able to catch and inactivate drug molecules by specific enzymes and thereby reduce the antibiotic influx into the matrix [34] . Deeper-located bacteria have lower metabolic activity, meaning that they are more resistant to antibiotics [40] . According to the Lewis model, the antibiotic treatment does not eliminate insensitive persister cells, which renew the biofilm after the cessation of therapy [25] . In some cases, such as microbial balance within the intestinal tract, biofilm formation can be beneficial. However, it is often an unwanted action, due to serious health problems and increased the cost of treatment and implant production. Counterfactual instantiation of bacteria community formation is a process called swarming ( Figure 1D ). It is a type of multicellularity characterised by the migration of highly differentiated cells (swarm cells) on semi-solid surfaces [25] . In the first phase of swarm raft formation, planktonic cells differentiate into long, multi-flagellated swarm cells, and stay in close proximity to each other, and then migrate onto semisolid surfaces as a single unit, analogous to a raft [41] . However, in liquid media, swarm rafts revert to the planktonic state. The process of swarming has been detected in Bacillus subtilis (G+), Salmonella typhimurium (G-) and P. aeruginosa (G-). The bacteria which formed rafts were insensitive after exposure to very high concentrations of antibiotics of many classes, in contrast to the swarm cells which return to the planktonic state [42, 43] .
The described mechanisms are an effective way to protect bacteria against commonly used antibiotics [44] . Although modern medicine allows the production of new antimicrobial agents using uncultured microorganism species, which do not grow under laboratory conditions [45] , sooner or later bacteria can evolve a resistance mechanism against these drugs. In fact, the progress of drug development does not follow the development of bacteria resistance [46] .
Bacterial resistance, in addition to the generation of large expenses in public health, also raises the need to increase drug doses, and, therefore, can enhance the side effects of treatments and deteriorate patient health. That is why modern nanotechnology solutions can efficiently support, and in the longer term replace, the previously used antimicrobial agents.
Biopotential of nanotechnology
A variety of forms, sizes and types of nanomaterials may be used in theranostic applications. A nano-theranostic is a system integrated into a single platform, which allows targeted therapy and monitoring response to the treatment [47] . This approach significantly affects the efficiency of the applied action, and can be used not only in cancer therapy [48] , but also in cases of metabolic diseases and nutrient deficiencies [49] , as well as bacterial infections [50] . Unique magnetic, luminescent and catalytic properties of nanostructures can lead to cost-effective diagnosis and also fast and highly selective treatments. It is possible to detect a single bacterium cell within 20 min by amplifying the signals caused by conjugation of nanoparticles with a specific antibody [51] . Supermagnetic iron-oxide nanodetectors can also assess bacterial metabolic activity in milk and blood [52] . Nanotechnology products can also be used for the prevention of infectious diseases, in particular against pathogens with a highly variable genetic composition. In conventional vaccines, there is a problem with degradation followed by clearance [53] . Nanostructures can serve as a vaccine platform, improving their safety and efficacy [54] .
Antibacterial properties of nanostructures
The antimicrobial properties of nanomaterials have been widely studied [55] (Table 1) ; the result is their multidirectional use in clothes, food, cosmetics and household appliances [66] [67] [68] [69] . Nano-implementation also finds a potential use in the pharmaceutical industry and other biomedical fields. The application of nanostructures is more important [65] now than ever before, due to the lowest level of new antibiotics being approved for 30 years [46] . Some nanostructures independently show antimicrobial properties, while others increase the effectiveness and safety of traditional antibiotics [70] . Furthermore, the production of nanodrugs may be cost-effective due to their stability for long-term storage and strength for harsh conditions [71] . Nanomaterials with antibacterial activity are both metallic and non-metallic structures such as various forms of carbon and nitric oxide, and also organic ones like chitosan, with the specific mechanism of bactericidal action (Figure 2 ).
Metal-containing nanomaterials
The most popular nanoforms are nanoparticles of metals and their oxides. The group of metal nanomaterials is very diverse. It consists, among others, of silver (Ag), copper (Cu) and gold (Au), and zinc (ZnO), titanium (TiO 2 ), and ferric (Fe 2 O 3 ) oxides. A multiple mechanism of killing and/or inhibiting the growth of microorganisms is characteristic for metal nanomaterials, and can prevent the development of bacterial resistance. The antimicrobial efficiency of nanomaterials depends on the type of material, methods of production and physicochemical characteristics, like size, shape and charge. Nanoparticles smaller than 10 nm [72] with irregular shape [11] are more active. The effectiveness of nanostructures is also speciesdependent [47] . For example, the antimicrobial potency of TiO 2 is higher for viruses than bacterial walls and bacterial spores [70] .
Silver (Ag)
The most frequently used nanomaterials with antimicrobial properties are nanoparticles of Ag (nanoAg). This metal has been used against various microorganisms since ancient times, but has relatively small antiseptic properties in bulk form, meaning that high doses are needed, which in turn induces argyria and organ damage [73] . In contrast, in the nanometric size, Ag is becoming one of the most effective antimicrobial agents [74] . It is almost impossible to overdose on nanoAg because nanosize particles can easily pass through the defence structures of microorganisms, and very small doses are sufficient for successful and precise treatment. NanoAg exhibits antimicrobial properties via multiple mechanisms of action, which depend on the size, active surface and ability to release bactericidal Ag + ions [75] . Ag + ions, with a natural affinity to sulphur-containing and phosphorus-containing groups of the cell surface, can inactivate outer membrane proteins [6, 76] and/or create holes in the membrane [58, 75] . Disruption of the membrane causes an outflow of cytoplasmic contents of the cell and interferes with the natural gradient of H + . NanoAg can also accumulate in bacterial membranes of G+ (Streptococcus pyogenes) and G-(E. coli) [77] . When stored in the membrane, nanoparticles cause disintegration, respiration disorders and, ultimately, cell death [7] . Furthermore, after passing through cell barriers, nanoAg can affect molecular responses. They bind to and damage the DNA and RNA of pathogens [57] and can inhibit cell division by disrupting DNA replication processes. The other mechanism involves denaturation of the 30S ribosomal subunit, which prevents protein translation [58] . Ag + ions inhibit cytochromes of the electron transport chain of microorganisms and cause a disorder of the bacterial respiratory chain interacting with NADH dehydrogenase and inhibiting the synthesis of adenosine triphosphate [78] . Another antimicrobial action is the inhibition of cell wall synthesis in G+ bacteria [58] . A broad action of Ag + involves the formation of ROS and evoking intracellular oxidative stress.
The ROS occurs naturally at low concentrations in bacterial cells, but the presence of nanoparticles may markedly increase their levels. ROS reacts with different cell structures inducing lipid peroxidation, conversion of proteins or even causing damage to nucleic acids. The type of ROS generated depends on the pH. Under acidic conditions, ROS are formed in a process similar to Fenton's reaction, while in alkaline pH, this is in the redox reaction [79] . Li et al. [80] have shown that G+ species are more susceptible to the effects of ROS than G-bacteria.
There is a controversy regarding which kind of bacteria is more sensitive to nanoAg. G-bacteria have a thinner cell wall than G+ species, which allows nanoAg to cross through the cell wall more easily. However, negatively charged LPS on the outer membrane can trap and block positively charged nanoAg [58] . Nevertheless, nanoAg still shows cytotoxic properties against G-bacteria such as multidrug-resistant P. aeruginosa (G-) and ampicillin-resistant E. coli O157: H7 (G-) [58] . Despite many mechanisms of nanoAg action, few bacteria were found to be resistant to both Ag + and nanoAg, as a result of a long-term bacteria contact with nanoAg. However, this insensitivity is temporary and reversible, after breaking the nanoAg treatment. Supposedly, it is a result of the altered cell membrane structure, decreased permeability and increased efflux pump activity [75] .
Copper (Cu)
Cu is known as a cheap and effective ancient remedy and a promising antibacterial agent [81] . This metal undergoes rapid oxidation to Cu 2+ ions in the air as well as in the aqueous environment, but nanotechnology is able to produce more stable Cu nanoparticles (nanoCu), for example, stabilised with gelatine [60] . The nanoCu activity strictly depends on many physical factors, such as temperature, aeration, pH and of course concentration of nanostructures and bacteria [82] . For example, the low pH and the high temperature decrease the agglomeration of nanoCu, thereby increasing toxicity, because a lower agglomeration provides a more available surface area which is very important for interactions with bacterial membranes [82] . The antibacterial properties of nanoCu have been validated using metallic Cu [83] , copper oxide [84] and Cu iodide [82] . There are three main and the most accepted mechanisms of nanoCu biocidal activity. The first is connected to dissipation of the cell membrane, under the influence of nanoparticle accumulation [83] . Increased permeability of the outer membrane changes the proton motive force across the plasma membrane and causes the release of membrane proteins [59] . This action is caused by the natural affinity of Cu to amine and carboxyl groups on the surfaces of microbial cells. This implies that microorganisms rich in these groups, such as B. subtilis (G+), are more sensitive to nanoCu [85] . The second mechanism is the generation of ROS by highly concentrated Cu 2+ ions, causing oxidative damage to cellular structures and inhibiting both DNA replication and amino acid synthesis in microorganisms [70] . Nonetheless, there are some organisms that are not susceptible to copper ions, such as Shewanella oneidensis MR-1 (G-) because of their ability to reduce Cu 2+ [84] .
Zinc oxide (ZnO) and titanium dioxide (TiO 2 )
These metal oxides are known for their optical, electrical and chemical properties. Both ZnO and TiO 2 have a selective impact on bacteria and exhibit minimal harmful effects on human and animal cells [62] . Inorganic antibacterial materials are durable and heat-resistant [86] . ZnO is also bactericidal in a bulk form, such as in the form of a 1 μm size powder [87] . Evidently, the antibacterial activity of ZnO increases when the particle size decreases [86] . An additional value of ZnO and TiO 2 is their photocatalytic activity under UV light, thereby increasing their antibacterial potential, especially against E. coli (G-), P. aeruginosa (G-), S. aureus (G+), Enteroccocus hire (G+) and Bacteroides fragilis (G-) [88] . The photocatalysis takes place in a liquid phase; therefore, a preferred place of ZnO and TiO 2 action is aqueous suspensions (nanofluids) [89] . Unfortunately, they have an aptitude for aggregation, decreasing their effectiveness [90] . This disadvantage can be eliminated by an additional iron covering [91] . In the photocatalytic process, ZnO and TiO 2 generate ROS [80, 92] , including hydrogen peroxide (H 2 O 2 ) and hydroxyl radicals (˙OH). Moreover, they do not affect the whole body of the host, but only microorganisms because the microenvironment changes only locally, close to the bacteria [93] . As a consequence, these very potent oxidants with a broad reactivity action can affect bacterial membrane semi-permeability, interfere with oxidative phosphorylation and in some cases cause the death of microorganisms [35] . They both have low but still mutagenic properties, causing frameshift mutations [61] . Furthermore, ZnO naturally and strongly binds to bacterial membranes and destroys lipids and proteins [94] , causing an outflow of the cytoplasm and cell death. In addition, to facilitate ZnO cellular internalisation, the nanomaterial can be coated with polyvinyl alcohol, which makes it more biocompatible [95] . Studies by Tayel et al. [96] demonstrated that G+ bacteria are generally more sensitive to ZnO than G-.
Gold (Au)
The essentially inert and toxic nature of Au makes it an attractive compound for therapeutic nanoparticles. In comparison to Ag, gold nanoparticles (nanoAu) are less potent and have almost no antibacterial effect by themselves [97] . However, Au nanostructures, including nanocages and nanoshells, have unique optical properties, and can be used for antimicrobial treatments via irradiation with focused laser pulses of suitable wavelengths [98] . According to this report, Fe 3 O 4 NanoAu conjugated with vancomycin are capable of recognising pathogenic bacteria, and subsequently after activation by photothermic treatment, destroy over 99% of these pathogens. Another study showed that under certain conditions, Au 3+ ions derived from nanoAu exhibit photomutagenic activity against the S. typhimurium (G-) strain TA 102 [99] . This effect was enhanced by light irradiation and correlated with the formation of DNA-interfering ROS. Furthermore, the conjugation of nanoAu with amino-pyrimidines causes the disintegration of physiological processes and nucleic acids release of G-bacteria via the capture and isolation of Mg 2+ and Ca
2+
. Internalised nanoAu can interact with DNA, inhibiting protein synthesis [100] . Moreover, nanoAu are effective carriers of drugs, being able to prevent antibiotic resistance mechanisms of multiple drug-resistant bacteria. Ampicillin bound to Au surface showed an effective broad-spectrum bactericidal activity against both G-and G+ bacteria, and also against microorganisms not sensitive to ampicillin alone [97, 101] . A stable complex of Au nanoshells coated with ciprofloxacin had a high antibacterial activity against E. coli. Moreover, it has been demonstrated that a stable colloidal Au conjugated with an anti-leukaemic drug, 5-fluorouracil, exhibited noticeable antibacterial and antifungal activities against Micrococcus luteus (G+), Staphylococcus aureus (G+), P. aeruginosa (G-), E. coli (G-), Aspergillus fumigatus and Aspergillus niger [102] . It is also possible to conjugate nanoAu with antibodies and obtain highly selective antimicrobial effects. For example, nanoAu conjugated with anti-protein A antibodies showed activity against S. aureus (G+) [103] . Probably, nanoAu conjugated with a drug has multiple mechanisms of antibacterial action. Antibiotics or antibodies allow the nanoAu complex to enter into the bacterial cell while nanoAu ensures that the high concentration of drugs inhibits the production of bacterial enzymes and presumably attenuates efflux pump activity [97] . Therefore, nanoAu particles are promising carrier agents for targeted drug therapy.
Non-metallic nanostructures 4.2.1 Carbon-derived nanoparticles
There are many nano-allotropes of carbon (nanoC), such as fullerenes, nanotubes, graphene and diamond nanoparticles. They are widely used in the energy sector and electronic industry due to their optical and superconductor properties. Furthermore, the high absorption of various organic chemicals by active carbon is well known [104] . However, pure carbon is not soluble in water or in any physiological fluids. Carbonic materials have the predisposition to agglomerate in biological solutions, due to their hydrophobic nature [105] . A direct dispersion of carbon in water requires the assistance of dispersing agents, such as electrostatic stabilisation through covalently grafting polyethylene glycol star polymers onto the chemically activated surfaces and edges [106] .
Nevertheless, nanoC possesses very effective antibacterial properties [107] [108] [109] [110] .
Graphene is a two-dimensional monolayer of carbon atoms that are bonded together in a hexagonal honeycomb lattice [111] . Graphene is presumed to be the thinnest material in the world, and even in the nanostructures world, its thickness to surface area ratio is incredible. The mechanism of graphene interaction with biomolecules or cells depends on the site of interaction, which could be a surface or edges [109] . Data on the antibacterial properties of graphene are limited; therefore, the mechanisms of action are still not fully explained. Complex observations were made by Kurantowicz et al. [109] , which showed the bactericidal properties of graphene forms against Listeria monocytogenes (G+) and Salmonella enterica (G-). The tested microorganisms showed a strong affinity and attachment to the graphene oxide surface, and to the edges of pristine graphene. Sharp edges of graphene are also able to physically disrupt cell membranes. Graphene oxide might induce oxidative stress in E. coli (G-) as well [64] . However, the oxidation process probably occurs mainly at the edges of the graphene or at defective sites on the surface [64, 109] . Furthermore, different bactericidal mechanisms of graphene oxide decrease the production of bacterial ATP [112] .
Carbon nanotubes (CNTs) are hollow cylindrical seamless nanoforms with opened or closed ends, made of pure carbon atoms covalently bonded in hexagonal arrays [113] . We can distinguish single-walled carbon nanotubes (sCNTs), with a diameter 0.8-2 nm, and multiwalled nanotubes (mCNTs) with a diameter of 5-20 nm and a length of over 100 nm [114] . Good optical, thermal and mechanical properties of CNTs are the main advantages of this nanomaterial, which make them ideal for use in nanoelectronics and as semiconductors. They are also applicable for constructing biosensors and biodevices for detection and molecular delivery [115] . It seems that sCNTs are more useful for biological applications, and these can significantly reduce biofilm formation [65, 116] . Recent studies have indicated that CNT (particularly sCNTs) have the strongest antimicrobial properties among various carbon-based nanomaterials [65, 115] . The most likely mechanism of CNTs bactericidal action is via the physical damage of membrane cells. However, due to their high reductive activity, CNTs can also act on the bacteria cell directly or indirectly, through the formation of radical species [117] . Vecitis et al. [118] reported the electronic potential of CNTs and proposed the three-step sCNTs antimicrobial mechanism. Its phases are as follows: initial contact between sCNTs and bacteria, perturbation of the cell membrane and electronic structure-dependent bacterial oxidation [118] . It was also observed that after bacteria treatment with sCNTs and mCNTs the expression of stress-related genes was up-regulated. The effect was higher after sCNTs exposure, probably caused by a smaller diameter of sCNTs [65] . Unfortunately, CNTs are cytotoxic and can induce chronic inflammation [119] . Due to the poor aqueous dispersion, a potential use of CNTs requires stabilisation by surfactants or polymers [113] . It has been demonstrated that the mucin glycoprotein-like polymer coating rendered CNTs toxic [120] . Thus, CNTs have promising applicability, but also have potential health risks.
Nitric oxide (NO)
NO is a very potent antimicrobial free radical and molecular modulator of immune responses to infections. It is responsible, among others, for the functional activity, growth and death of many immune and inflammatory cell types, including T lymphocytes, antigen-presenting cells, mast cells, neutrophils and natural killer cells [121] . Unfortunately, cutaneous infections with acidified nitrite can cause inflammation [122] . Many elements of the immune system actively respond to NO; therefore, high doses of NO can induce toxic reactions against other tissues of the host organism [121] . Essential factors of NO application as an antibacterial agent are proper, stable and suitable vehicles. Appropriate solutions to reduce its negative effects include nanostructures releasing NO, such as silica nanoparticles, which are non-toxic to mammalian cells [123] , and nanocapsules composed of polyethylene glycol, chitosan, glucose and sodium nitrite [124] . NO-releasing silica nanoparticles are very effective against P. aeruginosa (G-) and E. coli (G-), but also against G+ S. aureus and Staphylococcus epidermidis and the fungus Candida albicans [123] . This kind of nano-treatment is also verified against methicillin-resistant S. aureus (G+) (MRSA), frequently leading to sepsis, where NO released from silane hydrogen nanoparticles was tested [125] .
However, there are microorganisms which have enzymes preventing toxic overgrowth of intracellular NO concentrations. Specifically, there are methicillin-sensitive S. aureus (G+) (MSSA) and the previously mentioned MRSA. These bacteria naturally synthesise lactate dehydrogenase, which allows S. aureus (G+) to maintain redox homeostasis during nitrosative stress [126] . However, the multidirectional action of nanostructures releasing NO ensures an effective fight against bacteria, so the likelihood that microbes will develop resistance to NO is low [127] . NO interacts directly with bacterial cells, and, as a lipophilic, uncharged molecule, easily transverses the lipid bilayer to reach important metabolic enzymes and DNA, crippling essential biological processes [124] . However, the main NO antibacterial mechanism is based on the formation of reactive nitrogen species (RNS) and the induction of nitrosative stress within the cell. Apart from NO, RNS includes nitric dioxide (˙NO 2 ), peroxynitrite (ONOO -), nitrosyl cation (NO + ) and nitrosyl anion (NO -), which are formed after the reaction of NO with superoxide (O 2 -) [127] . RNS is able to react with amino acids that are naturally present in bacterial cells, such as cysteine, methionine, tyrosine, phenylalanine and tryptophan. In this way, they modify essential bacterial proteins, including plasma membrane proteins [26] . Moreover, RNS damages nucleic acids, through broken strains of DNA, deamination of purines and pyrimidines, and the formation of basic sites [127] . At the same time, RNS inhibits the expression of DNA repair enzymes, including DNA alkyl transferases, whose cysteine residues are S-nitrosylated by RNS [35, 127] . Another method of RNS action is the inactivation of zinc metalloproteins, which inhibit microbial cellular respiration [128] . The reaction of RNS with the prosthetic groups of proteins, like iron-sulphur clusters, is also very significant. Iron is an essential part of enzymes such as nitric oxide synthase and guanylate cyclase. RNS causes the dissociation and permanent removal of Fe 2+ from cells [127] . Lipids peroxidation is also typical for RNS [127] . NO is able to inhibit Bacillus cereus (G+) spores, through reaction with thiols. In this manner, nitrosylating agents are formed with nitrosylate thiol residues on proteins of microbial cells [127] .
Organic nanostructures
Aside from chemical elements and compounds in the fight against drug resistant bacteria, there are other substances used, such as polysaccharides, including chitosan. It is a natural biopolymer chain of N-acetylgluosamine with polycationic construction and acetylamine or free amino groups, with spontaneous antimicrobial properties against bacteria, viruses and fungi [129] . However, chitosan is more effective against viruses and fungi than bacteria [70] . Chitosan, usually obtained by alkaline deacetylation from chitin, is presumed to be a cost-effective and technologically affordable disinfection compound. Among others, its key advantage is very low toxicity to human and animal cells because of its biodegradable and biocompatible properties [130] . Native chitosan is only slightly soluble in water, resulting in poor solubility in the physiological environment. Therefore, chitosan's antimicrobial properties are highly improved when present in a water-soluble nanoform [131] . It was observed that nanoparticles containing high molecular weight chitosan have a higher activity against G+ bacteria, while low molecular weight chitosan has higher antibacterial activity against G-bacteria [132] . Chitosan has a positive electric charge. Reducing this polysaccharide to nanosize causes an increased area to volume ratio and also increased density of the positive charge on the surface. Thus, chitosan can move closer to the bacterial cell via electrostatic forces, and then pass through the wall and cell membrane of microorganisms, forming pores. This phenomenon significantly increases cell membrane permeability, disturbs osmotic stability, potentially induces leakage and may consequently cause cell lysis [133] . The derivatives of nanochitosan disrupt the outer and inner cell membrane more effectively than native chitosan [134] . Furthermore, due to the positive charge of chitosan amino groups, this nanostructure can also interact with Mg 2+ and Ca 2+ cations which normally stabilise LPS of G-bacteria. This action also increases the permeability of bacterial outer membrane [135] . The antimicrobial mechanisms of chitosan have also been explained by other processes. Chitosan inhibits the activities of enzymes and microbial growth through chelating trace metals [136] . In this way, nanochitosan can be used against biofilm formation. It also interferes with DNA in bacterial and fungal cells, thereby inhibiting the transcription of mRNA and, hence, protein translation [129] . Another antimicrobial property of chitosan is wound healing through the increased recruitment of fibroblasts and inhibition of the release of inflammatory cytokines [135] .
Antimicrobial drug nanoplatforms
Natural properties of nanostructures allow them to be combined with biologically active substances, or other nanomaterials, and used as efficient carriers of drugs and diagnostic agents. Therefore, nanoplatforms can potentially be used, among others, in gene therapy and labelling of cells [137] .
The use of nanoplatforms as vehicles allows the more efficient and targeted action on a specific tissue or pathogen, consequently being less toxic to the whole organism [138] . Nanocarriers can act by active or passive mechanisms. The passive pathway depends on the increased permeability of infected cells, while the active mechanism is based on receptor-ligand interactions (e.g. antibody) and can be facilitated by specific cell responses, such as changes in pH or respiratory burst [128] . There is also a possibility of the external control of nano-transporters via radiowaves [128] .
Composite of nanoforms
To broaden the bactericidal spectrum of a single nanoform, they can be linked to nanomaterials with different attributes. The creation of nanocomplexes can also enhance antimicrobial properties of the components. A good example is a complex of metallic nanoparticles bound with chitosan, caused by a specific structure of chitosan with very high affinity to metallic nanoparticles binding. Complexes of this polysaccharide with Ag and/or Cu inhibit the growth of S. aureus (G+) and E. coli (G-) even at low doses [139] .
Beyond the gain of antimicrobial properties, the fusion of two or more nanocomponents can help to eliminate the toxic side effects of strong antibacterial nanoforms. Halogens like fluorine have very efficient antimicrobial properties, but at the same time, they are very toxic for the kidney and liver, and are able to induce the formation of methaemoglobin [140] . The proposed solution is a complex of fluoride with magnesium dioxide (MgO 2 ) nanoparticles, which are five times more efficient at absorbing and binding fluoride than MgO 2 in the crude form. It was demonstrated that the composite of fluoride nanoparticles with MgO 2 nanoparticles exhibited bactericidal properties against E. coli (G-) and Bacillus megaterium (G+), caused a disruption of the membrane potential and induced membrane lipid peroxidation, but could interact with chromosomal DNA without toxic effects [141] . Practical applications of magnesium fluoride (MgF 2 ) nanoparticles can prevent the formation of E. coli (G-) and S. aureus (G+) biofilm [142] .
Binding with the active substances
Another use of nanocarriers is a combination of nanomaterials with active substances. The combination enhances the ability to access the drug as the nanoplatform favours the passage of substances directly into the cell. It also creates the possibility of a controlled release rate. This link between nanostructures and drugs can be accomplished by two main processes: coating and encapsulation.
The coating is an allocation of an active substance outside the nanostructure, and can be based on covalent conjugates [143] . There are many examples of such a kind of drug delivery. Small doses of a biogenic produced with Trichoderma viride Ag nanoparticles associated with ampicillin, kanamycin, or erythromycin have strong antimicrobial effects against S. typhimurium (G-), E. coli (G-), S. aureus (G+) and Micrococcus luteus (G+) [144] . Furthermore, Au nanoparticles, although themselves not exhibiting antimicrobial properties, are effective drug carriers [97] . The Au-ampicillin complex showed bactericidal activity against bacteria resistant to ampicillin administered alone. Similar observations have been made in the case of Au nanoparticles coated with ciprofloxacin [145] . Au nanoparticles can also serve as vaccine transporters. A very novel therapeutic strategy is coating bacterial membranes with nanoparticles [146] . The created complex induces rapid activation and maturation of dendritic cells in the lymph nodes. Moreover, these nanoparticles were shown to evoke the immune response and elevate the production of interferon-γ of the treated mice [146] .
Another kind of nanoplatform is nanocapsules, which encapsulate active substances. Friedman and co-workers [127] using the biocompatible material formed nanoparticles, which hide NO in their interior. These nanoparticles (size: 10 nm) are composed of polyethylene glycol, chitosan, glucose and sodium nitrite. They have a bactericidal effect against G+ and G-bacterial strains that are resistant to standard antibiotic treatments, but the effects are not similar for all microorganisms [26] . NO-releasing nanocapsules have the ability to destroy the biofilm formed by S. aureus (G+), S. epidermidis (G+), P. aeruginosa (G-) and E. coli (G-) [123] . The application of glutathione-releasing nanocapsules causes the creation of S-nitrosoglutathione, one of the strongest naturally occurring nitrosating agents. The method allows new drugs to be obtained with prolonged activity periods when the concentration of active substances remains constantly high. Such drugs were found to be effective against E. coli (G-), P. aeruginosa (G-) and Klebsiella pneumoniae (G-) [124] . Nanocapsules may enclose conventional antibacterial substances in their interior. This form of distribution increases the effectiveness of administered drugs. The nanocapsules composed of chitosan and alginate, surrounding benzoyl peroxide, have a higher microbial activity against Propionibacterium acne (G+) than the same drug given alone [135] . The use of nanocapsules also minimises the cytotoxic effects of the active substance to the host cells [135] . Another form of encapsulation is nanoliposomes, which are spherical structures formed from at least one lipid bilayer coating, e.g. of cholesterol [147] . Active antibacterial substances confined in the liposomes, by the fusion of liposomes with the cell membrane, can enter into bacteria at considerably higher concentrations. The application of this method can prevent the formation of bacterial resistance, as a given dose is high enough to overcome the transmembrane micro-pumps, thus preventing removal of the active agent [148] . The method was found to be effective against E. coli (G-), P. aeruginosa (G-) and Klebsiella pneumoniae (G-).
To summarise this part, using nanoplatforms in a directed therapy offers multiple advantages. Drug distribution into a target is controlled and uniform. Furthermore, the rate of drug release is controlled and maintained; hence, the side effects can be minimised. Nanotechnology can also improve the solubility of drugs, thereby enhancing cellular internalisation [70] .
Potential risk of bacterial resistance to nanostructures
Unfortunately, the defence mechanisms of bacteria treated with nanomaterials have already been observed [58, 149] . Sawosz et al. [149] demonstrated that Salmonella enteritidis (G-) treated with Au nanoparticles caused the aggregation of nanostructures, removed them from the cell and finally fixed them within the flagella or a biofilm network. It has been demonstrated that G-bacteria can be resistant to heavy metal ions, which are removed from the cell through efflux pumps [27] . Such a mechanism takes place after a prolonged contact of the pathogens with nanoAg [58] . Furthermore, it was demonstrated [150] that aluminium oxide (Al 2 O 3 ) nanoparticles can cause the development of bacterial resistance by increasing horizontal gene transfer from E. coli (G-) to Salmonella (G-) in an aqueous medium by 200 times. The process is mediated by the plasmids RP4, RK2 and pCF10. Nevertheless, the potential of bacterial resistance to nanostructure is acquired much more slowly compared to traditional antibiotics [151] . Most antibacterial properties of nanostructures are based on multiple mechanisms occurring simultaneously, which significantly impedes the widespread development of resistance in bacteria.
Potential risk of widespread use of nanomaterials as antibacterial agents
From antibacterial agents, it is required that they inhibit bacterial growth and/or lead to bacterial death without being toxic to other cells. It has been proven that antibiotics influence not only bacteria but also exhibit toxic and immunotoxic effects on the human body, triggering haematopoiesis in the bone marrow, allergies and autoimmune diseases [21] . The potential applicability and also the associated health risks of using nanomaterials have been the subject of numerous studies [152, 153] . The hazard often depends not only on the physicochemical properties of nanostructures but also on the route of administration to the patient, such as inhalation, implantation or injection [154] . The increasing use of nanotechnology products leads to the accumulation of nanomaterials in the environment. This situation poses a potential threat to the beneficial (from the human view point) bacteria, which play an important role in bioremediation and nitrogen retention in the soil [155] . Nanostructures may also accumulate in higher organisms, so it is necessary to consider the possible consequences of such a phenomenon. Therefore, the issue of the biodistribution of nanomaterials in the body and their pharmacokinetics is an essential part of many studies. The bio-circulation of nanocompounds is closely correlated to their physical and chemical properties, such as the size, type of coating and physiological condition of the treated organism [156] . It was demonstrated that specialised nanodrugs can penetrate both the blood-brain barrier and the blood-placenta barrier [157, 158] . Nanocompounds effectively penetrate into the cells, usually through the mechanism of endocytosis, although each cell type may use their particular path of internalisation [159, 160] . De Jong et al. [161] showed that the tendency to accumulate the nanoAu in the different organs of the rat depends on the size of nanoparticles. After intravenous injection, the smallest structures (10 nm) were found in the brain, heart, kidneys, lungs and gonads, while larger nanoparticles were detected in the blood, liver and spleen. The biodistribution of nanomaterials also depends on the capacity of the body to self-clean. An important element of this process is the reticuloendothelial system [156] .
The affinity and effect of nanostructures in relation to different types of tissue is still not fully understood. It was found that the uncontrolled accumulation of nanocompounds in the tissues leads to inflammation and tumorigenesis [162] . In vitro studies have shown that nanoforms can be cytotoxic [163] and genotoxic [164] to human cells. However, less numerous in vivo studies have not always confirmed these observations. De Jong et al. [165] intravenously administered nanoAg to rats for 28 days, and found an increase in liver enzymes, but the liver histology showed no pathological changes.
Knowledge about the applicability of nanostructures in biological systems is rapidly developing, but is still a young area. However, at present, we still do not have sufficient analytical methods to comprehensively describe their mechanisms of action and to recognise potential risks. The medical application of each nanostructure requires further detailed in vitro and in vivo investigations.
Conclusion
The global problem of drug-resistant bacteria needs a modern solution. Antimicrobial properties of the nanostructures depend on their physicochemical properties, as well as the structure of the bacterium. Almost unlimited possibilities of the nano-biotechnology products allow them to be used not only as active antibacterial agents but also as nanoplatforms for the delivery of drugs or other compounds.
However, it has to be kept in mind that the use of nanomaterials instead of or in combination with antibiotic therapy should be strictly monitored. Unfortunately, there are still no appropriate technically advanced analytical tools, which could clearly confirm or exclude the possible toxicity. Public concerns about the widespread use of nanomaterials are related to the safe use of controversial elements, such as heavy metals, and their ability to penetrate and accumulate in the body. There are still a lot of crucial issues regarding the use of nanomaterials as antibacterial agents and drug carriers which have to be answered.
